期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

血管生成在口腔扁平苔藓发生发展中的作用

原文传递
导出
摘要 血管生成(Angiogenesis)是指从已有的微血管床上新生出以毛细血管为主的血管系统,它是许多生理和病理过程的基本事件之一。过度的血管生成是多种慢性炎症疾病及肿瘤的标志,可致疾病进行性发展。口腔扁平苔藓(OLP)是一种病因不明的慢性炎性疾病,WHO将其列入潜在恶性病变的范畴,近来血管生成在OLP发生发展中的作用受到关注,本文就相关研究进行综述。
作者 李海洋 吴中婷 周红梅
机构地区 四川大学.口腔疾病研究国家重点实验室 四川大学华西口腔医院黏膜科
出处 《临床口腔医学杂志》 2013年第5期308-309,共2页 Journal of Clinical Stomatology
基金 国家自然科学基金(81172581 81272962)
关键词 血管生成 口腔扁平苔藓 慢性炎症疾病
分类号 R781.5 [医药卫生—口腔医学]
  • 相关文献

参考文献23

  • 1Chung AS, Lee J, Ferrara N. Targeting the tumour vasculature:In- sights from physiological angiogenesis [J]. Nat Rev Cancer, 2010, 10 (7) : 505-514.
  • 2Potente, Gerhardt H,Carmeliet P. Basic and therapeutic aspects of angiogenesis [J]. Cell, 2011,146 (6) : 873-887.
  • 3Chung AS,Ferrara N. Developmental and pathological angiogenesis [J]. Annu Rev Cell Dev Biol, 2011,27:563-584.
  • 4Marrelli A, Cipriani P, Liakouli V, et al. Angiogenesis in rheumatoid arthritis: A disease specific process or a common response to chronic inflammation?[J] Autoimmun Rev, 2011,10 (10) :595-598.
  • 5Costa C,Incio J, Soares R. Angiogenesis and chronic inflammation: Cause or consequence?[J] Angiogenesis, 2007, 10(3) : 149-166.
  • 6Szekanecz Z, Koch AE. Mechanisms of disease:Angiogenesis in in- flammatory diseases [J]. Nat Clin Pract Rheumatol,2007,3 (11): 635-643.
  • 7Schnekenburger M, Karius T, Cerella C, et al. Targeting inflammatory cell signaling mechanisms:A promising road to new therapeutic a- gents in chemoprevention and cancer therapy [J]. J Exp Ther Oncol, 2011,9(1) : 1-4.
  • 8Ulrich CM, Bigler J, Potter JD. Non -steroidal anti -inflammatory drugs for cancer prevention: Promise, perils and pharmacogenetics [J]. Nat Rev Cancer, 2006, 6 (2) : 130-140.
  • 9Kobayashi H, Lin PC. Angiogenesis links chronic inflammation with cancer[J]. Methods Mol Biol, 2009, 511 : 185-191.
  • 10Hussein MR. Evaluation of angiogenesis in normal and lichen planus skin by cd34 protein immunohistochemistry: Preliminary findings [J]. Cell Biol Int, 2007, 31 (10) : 1292-1295.

二级参考文献15

  • 1李亚琴,曹兰芳.肾上腺糖皮质激素在幼年特发性关节炎中的应用进展[J].中国当代儿科杂志,2009,11(3):240-242. 被引量：4
  • 2刘曦,刘爱京,邵福灵.沙利度胺治疗风湿性疾病机制的研究进展[J].中华风湿病学杂志,2006,10(6):366-368. 被引量：19
  • 3Singhal S, Mehta J, Desikan R, Ayers D, Roberson P, Eddlemon P, et al. Antitumor activity of thalidomide in refractory multiple myeloma[J]. NEnglJMed, 1999, 341 (21) :1565-1571.
  • 4Palumbo A, Bertola A, Musto P, Caravita T, Callea V, Nunzi M et al. Oral melphalan, prednisone, and thalidomide for newly di agnosed patients with myeloma [ J ]. Cancer, 2005, 104 (7) 1428-1433.
  • 5Cuadrado MJ, Karim Y, Sanna G, Smith E, Khamashta MA, Hughes GR. Thalidomide for the treatment of resistant cutaneous lupus : efficacy and safety of different therapeutic regimens [ J ]. Am J Med, 2005, 118(3) : 246-250.
  • 6Breda L, Nozzi M, Sanctis S, Chiarelli F. Laboratory tests in the diagnosis and follow-up of pediatric rheumatic diseases : an update [J]. Semin Arthritis Rheum, 2010, 40( 1 ) : 53-72.
  • 7Lazzerini M, Martelossi S, Marchetti F, Scabar A, Bradaschia F, Ronfani L, et al. Efficacy and safety of thalidomide in children and young adults with intractable inflammatory bowel disease: long-term results[ J ]. Aliment Pharmaeol Ther, 2007, 25 (4) :419-427.
  • 8Galustian C, Labarthe MC, Bartlett JB, Dalglcish AG. Thalido- mide-derived immunomodulatory drugs as therapeutic agents [ J ]. Expert Opin Biot Ther, 2004, 4 ( 12 ) : 1963-1970.
  • 9Lehman TJ, Striegel KH, Onel KB. Thalidomidc therapy for recal- citrant systemic onset juvenile rheumatoid arthritis[ J]. J Pediatr, 2002, 140( 1 ) :125-127.
  • 10Lehman TJ, Seheehter SJ, Sundel RP, Oliveira SK, Huttenlocher A, Onel KB. Thalidomide for severe systemic onset juvenile rheu- matoid arthritis: A multicenter study [ J]. J Pediatr, 2004, 145 (6) :856-857.

共引文献7

临床口腔医学杂志
2013年 第5期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部